5 Low-Debt Biotech Stocks Forecasted For Growth

Not only is biotechnology considered to be a riskier category for investments, but companies in this sector tend to burn through cash during their research and development phases. It takes a considerable amount of money to launch an effective product. For successful investing in this category, it is key to align with biotech stocks that have not over utilized debt to fund growth. For our scan today we used two filters. For the first one, we focused on biotech companies that have kept their capital structure intact by not over borrowing. Then we looked for projected EPS growth rates above 25% for the coming year. Take a look at the biotech stocks we gathered to see if any spark your interest.EPS growth (earnings per share growth) illustrates the growth
... Read the rest at SeekingAlpha.com